Research Articles | Page 74 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes Jun 2017 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Standardized High-Sensitivity Flow Cytometry Testing for Paroxysmal Nocturnal Hemoglobinuria in Children with Acquired Bone Marrow Failure Disorders: A Single Center U.S. Study Jun 2017 Cytometry B Clin Cytom paroxysmal nocturnal hemoglobinuria (PNH)
Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents Jun 2017 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy. Jun 2017 Oncotarget myelodysplastic syndromes (MDS)
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy Jun 2017 Br J Haematol myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways Jun 2017 J Immunol paroxysmal nocturnal hemoglobinuria (PNH)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Jun 2017 Semin Hematol
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Jun 2017 Semin Hematol myelodysplastic syndromes (MDS)
First-line Therapeutic Strategies for Myelodysplastic Syndromes. Jul 2017 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Share with addtoany.com.